Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Todd M, Brown"'
Autor:
Ene M. Enogela, Parag Goyal, Elizabeth A. Jackson, Monika M. Safford, Stephen Clarkson, Thomas W. Buford, Todd M. Brown, D. Leann Long, Raegan W. Durant, Emily B. Levitan
Publikováno v:
Discover Social Science and Health, Vol 4, Iss 1, Pp 1-12 (2024)
Abstract Background Among individuals with heart failure (HF), racial differences in comorbidities may be mediated by social determinants of health (SDOH). Methods Black and White US community-dwelling participants in the REasons for Geographic and R
Externí odkaz:
https://doaj.org/article/6b3e681d4e9c480188dd84c2e6531bed
Autor:
Monika M Safford, Todd M Brown, Emily B Levitan, Madeline R Sterling, Joanna Bryan Ringel, Orysya Soroka, Raegan W Durant
Publikováno v:
BMJ Public Health, Vol 1, Iss 1 (2023)
Objective To examine associations between myocardial infarction (MI) and multiple physical function metrics.Methods Among participants aged≥45 years in the REasons for Geographic And Racial Differences in Stroke prospective cohort study, instrument
Externí odkaz:
https://doaj.org/article/6200d3a2b5e7496e8bdf99cb9fbe03f5
Autor:
Chibuike J. Alanaeme, Vera Bittner, Todd M. Brown, Lisandro D. Colantonio, Nafeesa Dhalwani, Jenna Jones, Bethany Kalich, Jason Exter, Elizabeth A. Jackson, Emily B. Levitan, Bharat Poudel, Zhixin Wang, Mark Woodward, Paul Muntner, Robert S. Rosenson
Publikováno v:
American Heart Journal Plus, Vol 21, Iss , Pp 100201- (2022)
Study objective: The 2018 American Heart Association/American College of Cardiology (AHA/ACC) cholesterol guideline recommends a maximally-tolerated statin with add-on lipid-lowering therapy, ezetimibe and/or proprotein convertase subtilisin/kexin ty
Externí odkaz:
https://doaj.org/article/3852eefabfaa4b5e96d2c7e5af5f882f
Autor:
Lisandro D. Colantonio, Vera Bittner, Monika M. Safford, Santica Marcovina, Todd M. Brown, Elizabeth A. Jackson, Mei Li, J. Antonio G. López, Keri L. Monda, Timothy B. Plante, Shia T. Kent, Paul Muntner, Robert S. Rosenson
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 11 (2022)
Background It is unclear whether lipoprotein(a) is associated with coronary heart disease (CHD) and ischemic stroke events in White and Black adults with atherosclerotic cardiovascular disease (ASCVD). Methods and Results We conducted a case‐cohort
Externí odkaz:
https://doaj.org/article/dee9523a83154151a2146b33a52a1bcd
Autor:
Demetria Hubbard, Lisandro D. Colantonio, Robert S. Rosenson, Todd M. Brown, Elizabeth A. Jackson, Lei Huang, Kate K. Orroth, Stephanie Reading, Mark Woodward, Vera Bittner, Orlando M. Gutierrez, Monika M. Safford, Michael E. Farkouh, Paul Muntner
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-9 (2021)
Abstract Background Adults who have experienced multiple cardiovascular disease (CVD) events have a very high risk for additional events. Diabetes and chronic kidney disease (CKD) are each associated with an increased risk for recurrent CVD events fo
Externí odkaz:
https://doaj.org/article/b2266f52c5094a4091cdd331dbc82fba
Autor:
Demetria Hubbard, Emily C. McKinley, Lisandro D. Colantonio, Bharat Poudel, Robert S. Rosenson, Todd M. Brown, Elizabeth A. Jackson, Lei Huang, Kate K. Orroth, Katherine E. Mues, Paul J. Dluzniewski, Vera Bittner, Paul Muntner
Publikováno v:
American Heart Journal Plus, Vol 13, Iss , Pp 100121- (2022)
Study objective: Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce the risk for atherosclerotic cardiovascular disease (ASCVD) events in patients with diabetes and ASCVD. W
Externí odkaz:
https://doaj.org/article/13e6ea4063bf43b5b251b7b09204fff3
Autor:
Matthew T. Mefford, Santica M. Marcovina, Vera Bittner, Mary Cushman, Todd M. Brown, Michael E. Farkouh, Sotirios Tsimikas, Keri L. Monda, J. Antonio G. López, Paul Muntner, Robert S. Rosenson
Publikováno v:
Journal of Lipid Research, Vol 60, Iss 11, Pp 1946-1952 (2019)
The pharmacologic inhibition of proprotein convertase subtilisin-kexin type 9 (PCSK9) lowers lipoprotein (a) [Lp(a)] concentrations. However, the impact of genetic PCSK9 loss-of-function variants (LOFVs) on Lp(a) is uncertain. We determined the assoc
Externí odkaz:
https://doaj.org/article/d3387648d2aa41bda30df7af0a6912b8
Autor:
James M. Shikany, Monika M. Safford, Orysya Soroka, Todd M. Brown, P. K. Newby, Raegan W. Durant, Suzanne E. Judd
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 13 (2021)
Background Sudden cardiac death (SCD) is a common cause of death in the United States. Few previous studies have investigated the associations of diet scores and dietary patterns with risk of SCD. We investigated the associations of the Mediterranean
Externí odkaz:
https://doaj.org/article/8c222b25fb514f40a50c026729a4ee0c
Autor:
Madeline R. Sterling, Joanna Bryan Ringel, Laura C. Pinheiro, Monika M. Safford, Emily B. Levitan, Erica Phillips, Todd M. Brown, Parag Goyal
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 9 (2020)
Background Outcomes following heart failure (HF) hospitalizations are poor, with 90‐day mortality rates of 15% to 20%. Although prior studies found associations between individual social determinants of health (SDOH) and post‐discharge mortality,
Externí odkaz:
https://doaj.org/article/e81cd27ce0f446a68b90e5578b887d04
Autor:
Matthew Shane Loop, Melissa K Van Dyke, Ligong Chen, Todd M Brown, Raegan W Durant, Monika M Safford, Emily B Levitan
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0233161 (2020)
The beta blockers carvedilol, bisoprolol, and sustained-release metoprolol succinate reduce readmissions and mortality among patients with heart failure with reduced ejection fraction (HFrEF), based upon clinical trial and registry studies. Results f
Externí odkaz:
https://doaj.org/article/3d53b4f26eab494893b1267dc8439427